The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat

Transplantation

Volumn 84, Issue 11, 2007, Pages 1492-1499

  Vogelbacher, Regina ^a   Wittmann, Sandra ^a   Braun, Andrea ^a   Daniel, Christoph ^a   Hugo, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Everolimus; Five sixth nephrectomy; mTOR inhibitor; VEGF

Indexed keywords

CREATINE; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MESSENGER RNA; PROTEIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; FIBROSING ALVEOLITIS; FRACTIONAL FLOW RESERVE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY INFARCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SPRAGUE DAWLEY RAT; UNINEPHRECTOMY;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM; GLOMERULAR MESANGIUM; KIDNEY DISEASES; MALE; PROTEIN KINASES; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIROLIMUS; THROMBOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 37349107870     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000282866.92367.99     Document Type: Article

References (25)

1. Fervenza FC, Fitzpatrick PM, Mertz J, et al. Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies. Nephrol Dial Transplant 2004; 19: 1288.
2. Daniel C, Renders L, Amann K, et al. Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat. Am J Transplant 2005; 5: 2849.
3. Daniel C, Ziswiler R, Frey B, et al. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative. Exp Nephrol 2000; 8: 52.
4. Mohacsi PJ, Tuller D, Hulliger B, Wijngaard PL. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor. J Heart Lung Transplant 1997; 16: 484.
5. Wang W, Chan YH, Lee W, Chan L. Effect of rapamycin and FK506 on mesangial cell proliferation. Transplant Proc 2001; 33: 1036.
6. Schuler W, Sedrani R, Cottens S, et al. SDZ RAD, a new rapamycin derivative: Pharmacological properties in vitro and in vivo. Transplantation 1997; 64: 36.
7. Boratynska M, Banasik M, Watorek E, et al. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Transplant Proc 2006; 38: 101.
8. Lee LK, Meyer TW, Pollock AS, Lovett DH. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995; 96: 953.
9. Wu M, Wahl PR, Le Hir M, et al. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease. Kidney Blood Press Res 2007; 30: 253.
10. Nangaku M, Alpers CE, Pippin J, et al. A new model of renal microvascular endothelial injury. Kidney Int 1997; 52: 182.
11. Iruela-Arispe L, Gordon K, Hugo C, et al. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 1995; 147: 1715.
12. Mihatsch MJ, Bremer J. Acid fuchsin orange G-stain (AFOG) for glomerular protein deposits. Clin Nephrol 1978; 9: 259.
13. Johnson RJ. The glomerular response to injury: Progression or resolution? Kidney Int 1994; 45: 1769.
14. Hugo C, Hugo C, Pichler R, et al. The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J Clin Invest 1996; 97: 2499.
15. Kang DH, Kanellis J, Hugo C, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806.
16. Kang DH, Joly AH, Oh SW, et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001; 12: 1434.
17. Matsui K, Nagy-Bojarsky K, Laakkonen P, et al. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: Aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 2003; 14: 1981.
18. Hugo C, Shankland SJ, Pichler RH, et al. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 1998; 53: 302.
19. Daniel C, Takabatake Y, Mizui M, et al. Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo. Am J Pathol 2003; 163: 1185.
20. Jacobi J, Porst M, Cordasic N, et al. Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats. Kidney Int 2006; 69: 2013.
21. Flechner SM, Kurian SM, Solez K, et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 1776.
22. Butani L. Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue. Transplantation 2004; 78: 1362.
23. Keller K, Daniel C, Schocklmann H, et al. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy. Nephrol Dial Transplant 2006; 21: 2724.
24. Hermann P, Poschmann G, Bolliger S, et al. Mercuric chloride-induced glomerulopathy in BN-rats: Application to preclinical drug testing. Transplant Proc 1993; 25: 2826.
25. Bonegio RG, Fuhro R, Wang Z, et al. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol 2005; 16: 2063.